Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1Recruiting 1Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1CNS 1

Conditions

Glioblastoma 11Glioma 4Sarcoma, Ewing 2Recurrence 2Medulloblastoma 2Brain Neoplasms 2Triple Negative Breast Neoplasms 1Solid Tumor Cancer 1Sarcoma 1SCLC, Extensive Stage 1Rhabdomyosarcoma 1Primary Glioblastoma 1Pancreatic Neoplasms 1Osteosarcoma 1Melanoma 1Lymphoma, Follicular 1Hypoxia 1Ependymoma 1Diffuse Intrinsic Pontine Glioma 1Astrocytoma 1Advanced Glioblastoma 1

Interventions

Lenalidomide 4Rituximab 3zanubrutinib 2tafasitamab 2fludarabine 2Magnetic Resonance Spectroscopy 2Cyclophosphamide 2vorasidenib 1tislelizumab 1resiniferatoxin 1relmacabtagene autoleucel 1pomalidomide 1orelabrutinib 1obinutuzumab 1loncastuximab tesirine 1duvelisib 1Transurethral Resection of Bladder 1Temozolomide 1Standard of Care 1Spinal Puncture 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Prednisone 1Oxygen Consumption 1Interleukin-2 1Inhalation 1Furosemide 1Eflornithine 1Diet 1Bendamustine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Lymphoma, Follicular × Temozolomide × Clear all
NCT07215910 2025-10-14

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Not yet recruiting
408 enrolled
CNSLymphoid

Astrocytoma, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡